Form 4: Immunome CSO Gifts Shares to Children's Custodial Accounts

Immunome Inc.'s Chief Scientific Officer, Jack Higgins, gifted 3,000 shares of common stock to custodial accounts for his children.

Summary

• Jack Higgins, Chief Scientific Officer of Immunome Inc. (IMNM), reported a change in beneficial ownership.
• On December 19, 2025, Higgins gifted a total of 3,000 shares of Immunome common stock.
• The shares were transferred to three separate custodial accounts, each receiving 1,000 shares, established for his children under the Uniform Transfer to Minors Act.
• Higgins serves as the custodian for these accounts but disclaims beneficial ownership of the gifted shares.
• The transactions were reported with a price of $0, consistent with a gift.
• Following these transactions, Higgins' direct beneficial ownership decreased from an initial 39,729 shares to 37,729 shares.
• Each custodial account now indirectly holds 1,000 shares, totaling 3,000 indirect shares for which Higgins is custodian.
• The gifted shares are subject to a lock-up agreement dated December 15, 2025, which the transferees have agreed to honor.

Sentiment

Score: 5

Explanation: Neutral. This is a routine insider transaction (gift) and does not inherently reflect positively or negatively on the company's operational or financial performance. The transfer to custodial accounts with a lock-up agreement suggests a long-term view but is a personal financial decision.

Positives

• The transfer of shares to custodial accounts, even with a reduction in direct ownership, can be interpreted as a long-term commitment by the Chief Scientific Officer to the company's future value, as he is entrusting shares to his children's future.

Negatives

• The direct beneficial ownership of common stock by a key executive, Jack Higgins, decreased by 3,000 shares, although this is offset by his indirect ownership as custodian for his children.

Risks

• The gifted shares are subject to a lock-up agreement entered into on December 15, 2025, which restricts their liquidity for a specified period, potentially limiting the ability to sell these shares if needed.

Future Outlook

The filing does not contain forward-looking statements or guidance regarding the company's future performance, focusing solely on an insider's stock transaction.

Management Comments

• The Reporting Person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares for purposes of Section 16 or for any other purpose.
• The shares are subject to a lockup agreement entered into by the Reporting Person on December 15, 2025 (the 'Lock-up Agreement'). The transferee has agreed to be bound by the terms of the Lock-up Agreement.

Industry Context

This Form 4 filing details an individual insider transaction and does not provide information directly related to broader industry trends or the competitive landscape. It reflects a personal financial decision by a key executive.

Comparison to Industry Standards

• This filing is a standard insider transaction report (Form 4) and does not contain information that allows for a comparison of company results to global benchmarks or specific comparable companies/projects. It solely reports a change in beneficial ownership by an executive.

Related Party Transactions

• Gift of 3,000 shares of common stock by Chief Scientific Officer Jack Higgins to custodial accounts for his children, for which he serves as custodian.

Stakeholder Impact

• Shareholders: A minor reduction in direct insider ownership, but shares remain indirectly controlled by the insider as custodian. The lock-up agreement might provide some stability regarding these specific shares.
• Employees, Customers, Suppliers, Creditors: No direct impact from this personal stock transaction.

Next Steps

• The filing does not specify any future actions or milestones for the company, as it pertains to a past insider transaction.

Key Dates

Recommendation

This Form 4 filing reports a personal gift of shares by a Chief Scientific Officer to his children's custodial accounts. While it reduces his direct beneficial ownership, he retains indirect control as custodian, and the shares are subject to a lock-up agreement. This transaction is a personal financial decision and does not provide new information about the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate as there's no new fundamental catalyst.

Keywords

Immunome Inc., IMNM, Jack Higgins, Chief Scientific Officer, Insider Transaction, Form 4, Stock Gift, Beneficial Ownership, Custodial Account, Lock-up Agreement